Search Results 171-180 of 18134 for monoclonal antibody
ADC biology. One promising novel therapeutic approach uses antibody-drug conjugates (ADC). ADCs combine monoclonal antibodies and cytotoxic payloads to target ...
Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... antibodies and the factors that may ...
Monoclonal antibodies, such as nivolumab, may block tumor growth in different ... History of severe hypersensitivity reaction to any monoclonal antibody ...
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...
Immunotherapy with monoclonal antibodies, such as ... Brentuximab vedotin is a monoclonal antibody, brentuximab, linked to a toxic agent called vedotin.
... monoclonal antibody) in subjects with relapsed or refractory Multiple Myeloma. Participation eligibility. Participant eligibility includes age, gender, type ...
This novel anti-CD3 monoclonal antibody therapy, which slows immune-mediated beta cell destruction, is approved by the Food and Drug Administration for children ...
Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...
Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.